文献速递口腔修复与种植

钛基基台单种植体支持氧化锆冠的7.5年前瞻性队列临床结局

Clinical outcomes of single implant supported crowns utilising the titanium base abutment: A 7.5-year prospective cohort study.
PubMed 文献 · J Dent · 2024-08-16

这项前瞻性队列研究评估了24例患者使用钛基基台(TBA)的单颗氧化锆种植冠在7.5年时的影像学、临床和患者报告结局。18例患者完成7.5年复查,边缘骨水平稳定,种植体周围黏膜炎患病率50%,无种植体周围炎,修复体生存率94.4%,患者满意度高。

要点

  • 7.5年边缘骨水平稳定,与基线及1年随访无显著差异。
  • 探诊深度显著增加,但出血和菌斑控制无显著变化。
  • 修复体生存率94.4%,患者满意度高,无种植体周围炎。

核心结论

  • 钛基基台单种植体支持氧化锆冠在7.5年时技术并发症少、修复体生存率高、边缘骨水平稳定且患者满意度高。

研究设计与样本

  • 前瞻性队列研究,24例患者接受骨水平钛种植体并采用钛基基台的螺丝固位氧化锆种植冠。
  • 在冠交付(基线)、1年(FU-1)和7.5年(FU-7.5)随访时评估边缘骨水平、临床参数、技术并发症和患者满意度。
  • 7.5年时18例患者可进行复查。

主要发现

  • FU-7.5时平均边缘骨水平为0.35±0.20mm,与基线0.54±0.39mm(p=.352)和FU-1的0.54±0.45mm(p=0.524)相比无显著变化。
  • 从基线到7.5年,平均探诊深度从3.0±0.6mm显著增加至3.7±0.8mm(p=0.005)。
  • 出血和菌斑控制无显著变化:出血从27.1±20.7%至25.0±20.0%(p=0.498);菌斑从11.1±21.2%至25.0±25.1%(p=0.100)。
  • 9例患者有超过一个出血位点,种植体周围黏膜炎患病率50%,无种植体周围炎。

临床怎么用

  • 钛基基台可作为中期种植支持修复的合适基台选择,临床性能满意。
  • 需关注探诊深度增加和种植体周围黏膜炎的发生,加强随访监测。

局限性

  • 样本量较小,7.5年时仅18例患者完成复查。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess radiographic, clinical and patient-reported outcomes of single zirconia implant-supported crowns on titanium base abutments (TBA) over a 7.5-year period. METHODS: Twenty-four patients received bone-level titanium implants and screw-retained zirconia implant crowns utilising TBA. Marginal bone level (MBL), clinical parameters (probing depth-PD, bleeding on probing-BoP, plaque control record-PCR), technical complications (USPHS criteria) and patient satisfaction were assessed at crown delivery (baseline), 1 year (FU-1) and at 7.5 years (FU-7.5) of follow-up. RESULTS: Eighteen patients were available for re-examination at 7.5 years. The mean MBL at FU-7.5 (0.35 ± 0.20mm) did not significantly change compared to baseline (0.54 ± 0.39, p=.352) and to FU-1 (0.54 ± 0.45mm, p=0.524). From baseline to 7.5 years, the mean PD increased significantly, from 3.0 ± 0.6mm to 3.7 ± 0.8mm (p=0.005). However, BoP and PCR did not significantly change; (BOP: from 27.1 ± 20.7% to 25.0 ± 20.0%, p=0.498; PCR: from 11.1 ± 21.2% to 25.0 ± 25.1%, p=0.100). Nine patients presented with more than one bleeding site. This denoted a peri-implant mucositis prevalence of 50%, whilst none of the implants presented peri-implantitis. One incidence of minor and major ceramic chipping were reported on 2 out of the 18 crowns, resulting in a prosthetic survival rate of 94.4%. Seventeen patients were highly satisfied with their result. CONCLUSION: Single implant-supported zirconia crowns on TBA displayed: (i) minor number of technical complications, (ii) high prosthetic survival rate, (iii) stable marginal bone level and (iv) high patient satisfaction at 7.5 years. CLINICAL IMPLICATIONS: Titanium base abutments despite their high use in clinical practice, lacked medium- and long-term studies. The presented findings highlight their clinical performance at 7.5 years as they display satisfying radiographic, clinical and patient-related outcomes. TBA appear to be a suitable abutment choice for medium-term implant-supported restorations.

来源:J Dent,查看原文。版权归原作者所有。

引用

  1. Smirani R, Chantler JG, Endres J, et al. Clinical outcomes of single implant supported crowns utilising the titanium base abutment: A 7.5-year prospective cohort study. J Dent. 2024. PMID: 39154834. doi:10.1016/j.jdent.2024.105306

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。